Saturday 17 October 2026 Export CORT’s income statement to Excel — free account

Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $761.4 million, up 12.8% from fiscal 2024. In the quarter to June 2026, revenue grew 31.7%, EPS grew 21.2% and free cash flow fell 29.9%, each against the same quarter a year earlier. Revenue growth for ten consecutive years; insiders bought in the last twelve months.

110.16 3.21 −2.83%

Follow CORT

Alert me

Market cap: $12.3B
P/E: 212×
Fwd P/E: 139×
Dividend yield: —
F-score: 4/9
Altman Z: 14.11
Beneish M: −2.76
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	167.21	89.58	37.02	83.11	+8 more quarters Free account
P/S ratio Full definition →	11.03	5.47	4.75	11.61
P/FCF ratio Full definition →	85.69	35.04	25.49	52.69
P/Operating CF Full definition →	273.16	(251.00)	94.01	157.96
P/B ratio Full definition →	12.98	6.60	5.58	13.62
Price to Tangible BV Full definition →	12.98	6.60	5.58	13.62
EV/Sales Full definition →	10.68	5.05	4.28	11.06
EV/EBITDA Full definition →	2,382.98	0.00	78.33	145.12
EV/Operating CF Full definition →	80.85	32.27	22.94	50.12
EV/FCF Full definition →	82.95	32.35	22.97	50.20
Quick Ratio Full definition →	2.50	2.53	2.60	2.85
Current Ratio Full definition →	2.86	2.86	2.92	3.14
Net Debt/EBITDA Full definition →	(7.31)	6.90	2,739.77	(38.93)
Debt/Assets Full definition →	0.00%	0.00%	0.60%	0.64%
Debt/Equity Full definition →	0.00	0.00	0.01	0.01
Asset Turnover Full definition →	0.98	0.93	0.91	0.92
Operating CF/Net income Full definition →	0.80	0.54	1.61	2.81
Capex/Depreciation Full definition →	(2.93)	(0.34)	0.01	0.00
Research and Development Expense of Revenue Full definition →	21.04%	40.18%	32.09%	33.16%
Selling, General and Administrative Expense of Revenue Full definition →	61.25%	88.15%	64.43%	59.71%
Intangible Assets out of Total Assets Full definition →	0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →	11.48%	13.97%	10.27%	11.02%
Graham Net Nets Full definition →	0.03	0.06	0.08	0.04
Graham Number Full definition →	8.85	7.86	11.49	11.72
Earnings Yield Full definition →	0.60%	1.12%	2.70%	1.20%
Free Cash Flow Yield Full definition →	1.17%	2.85%	3.92%	1.90%
Revenue per Share Full definition →	2.43	1.58	1.95	2.01
Operating CF per Share Full definition →	0.32	(0.16)	0.37	0.53
Capex per Share Full definition →	(0.02)	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	0.29	(0.16)	0.37	0.53
Cash per Share Full definition →	2.92	3.24	3.58	4.07
Shareholders Equity per Share Full definition →	6.70	6.11	6.24	6.10
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	6.70	6.11	6.24	6.10
Free Cash Flow Full definition →	31.02	(16.97)	38.40	54.48
Working Capital Full definition →	285.87	276.85	319.38	368.87
Capital Expenditures Full definition →	(2.53)	(0.20)	(0.05)	0.00
Net Current Asset Value Full definition →	256.75	249.14	296.62	349.43
EV/EBIT Full definition →	1,384.77	0.00	72.71	125.05
Capex to Sales Full definition →	0.01	0.00	0.00	0.00
Price to Operating Income Full definition →	1,430.53	0.00	80.68	131.24
Other line items
Average Receivables Full definition →	70.74	50.45	56.88	64.67
Average Payables Full definition →	19.22	30.63	27.91	26.52
Average Inventory Full definition →	12.73	13.63	12.64	10.20
Average Assets Full definition →	845.21	830.67	838.60	803.93
Average Common Equity Full definition →	670.78	660.64	663.70	635.37

Show all line items

Columns are period end dates

Stockrow Weekly